Drug Profile
MNT 03 01
Alternative Names: MNT-03-01Latest Information Update: 05 Sep 2023
Price :
$50
*
At a glance
- Originator Microbial Novoteqs
- Class Antifungals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Mycoses
Most Recent Events
- 05 Sep 2023 Discontinued - Preclinical for Mycoses in USA (unspecified route)
- 28 Aug 2020 No recent reports of development identified for preclinical development in Mycoses in USA
- 11 Jul 2016 Preclinical trials in Mycoses in USA (unspecified route)